Literature DB >> 6609500

Cephalosporin resistance in strains of Klebsiella oxytoca isolated during antibiotic therapy.

R L Then, M P Glauser, P Angehrn, M Arisawa.   

Abstract

In the course of multiple antibiotic treatment of a seriously ill patient, a high level of resistance to cefamandole, cefuroxime and ceftriaxone was found among consecutive isolates of Klebsiella oxytoca, other species isolated remaining susceptible. Susceptibility to cefotaxime was less affected, and the activity of cefoxitin and moxalactam was unchanged. Resistant K. oxytoca strains synthesized a large amount of a broad-spectrum beta-lactamase, able to hydrolyze ceftriaxone, cefuroxime and cefotaxime. The enzyme level as well as the ability to hydrolyze different cephalosporins with different rates explained the in vitro susceptibilities observed reasonably well. The initially susceptible K. oxytoca strain easily converted in vitro to variants producing a high level of beta-lactamase after exposure to ceftriaxone, without concomitant acquisition of high-level resistance to this antibiotic, suggesting that additional and at present unknown factors also contributed to resistance of the clinical isolates.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6609500

Source DB:  PubMed          Journal:  Zentralbl Bakteriol Mikrobiol Hyg A        ISSN: 0174-3031


  5 in total

1.  Genomic Investigation Reveals Contaminated Detergent as the Source of an Extended-Spectrum-β-Lactamase-Producing Klebsiella michiganensis Outbreak in a Neonatal Unit.

Authors:  Paul Chapman; Brian M Forde; Leah W Roberts; Haakon Bergh; Debra Vesey; Amy V Jennison; Susan Moss; David L Paterson; Scott A Beatson; Patrick N A Harris
Journal:  J Clin Microbiol       Date:  2020-04-23       Impact factor: 5.948

2.  Activity of carumonam and aztreonam against Klebsiella species.

Authors:  C Roy; C Segura; R Reig; M Teixell; M Hermida; D Teruel; A Foz
Journal:  Eur J Clin Microbiol       Date:  1985-10       Impact factor: 3.267

Review 3.  beta-Lactamases in laboratory and clinical resistance.

Authors:  D M Livermore
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

Review 4.  Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  D M Richards; R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-06       Impact factor: 9.546

5.  Chromosomal beta-lactamase of Klebsiella oxytoca, a new class A enzyme that hydrolyzes broad-spectrum beta-lactam antibiotics.

Authors:  Y Arakawa; M Ohta; N Kido; M Mori; H Ito; T Komatsu; Y Fujii; N Kato
Journal:  Antimicrob Agents Chemother       Date:  1989-01       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.